$45.45
0[0.00%]
At close: Apr 25
$45.45
0[0.00%]
PreMarket: 4:20PM EDT
Vericel
(NASDAQ:VCEL)Latest News for Vericel Stock (NASDAQ:VCEL)
Vericel Stock (NASDAQ: VCEL)
Categories: All
Tuesday, March 26, 2024
Friday, March 01, 2024
- A Closer Look at 4 Analyst Recommendations For VericelBenzinga Insights - Mar 1, 2024, 10:00AM
- Truist Securities Maintains Buy on Vericel, Raises Price Target to $54Benzinga Newsdesk - Mar 1, 2024, 8:44AM
- HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $53Benzinga Newsdesk - Mar 1, 2024, 7:33AM
Thursday, February 29, 2024
- Vericel Forecasts 2024 Revenue Of $237M-$241M Versus Consensus Of $240.24M, With Gross margin Of Approximately 70% And Adjusted EBITDA Margin Of Approximately 20%Benzinga Newsdesk - Feb 29, 2024, 8:08AM
- Vericel Q4 GAAP EPS $0.26 Beats $0.17 Estimate, Sales $65.00M Beat $63.93M EstimateBenzinga Newsdesk - Feb 29, 2024, 7:56AM
- Earnings Scheduled For February 29, 2024Benzinga Insights - Feb 29, 2024, 5:15AM
Thursday, January 25, 2024
Tuesday, January 16, 2024
Tuesday, January 09, 2024
- Vericel shares are trading higher after the company announced better-than-expected preliminary revenue for FY23 and Q4.Benzinga Newsdesk - Jan 9, 2024, 11:51AM
- Vericel FY23 Prelim. Total Net Revenue Expected To Be $197.5M vs $195.04M Est., Q4 Revenue Expected To Be ~$65M vs $62.6M Est.Benzinga Newsdesk - Jan 9, 2024, 7:56AM
Thursday, December 28, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
- Vericel Raises 2023 Revenue Guidance From $190M-$197M To $192.5M-$197.5MBenzinga Newsdesk - Nov 8, 2023, 7:59AM
- Vericel Q3 EPS $(0.08) Vs $(0.14) Last Year, Sales $45.58M Beat $45.15M EstimateBenzinga Newsdesk - Nov 8, 2023, 7:57AM
- Earnings Scheduled For November 8, 2023Benzinga Insights - Nov 8, 2023, 4:21AM
Monday, October 16, 2023
Thursday, September 28, 2023
Thursday, September 21, 2023
- Truist Securities Reiterates Hold on Vericel, Maintains $39 Price TargetBenzinga Newsdesk - Sep 21, 2023, 12:55PM
- Stephens & Co. Reiterates Overweight on Vericel, Maintains $44 Price TargetBenzinga Newsdesk - Sep 21, 2023, 11:42AM
- Analyst Ratings for VericelBenzinga Insights - Sep 21, 2023, 9:00AM
- HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $44.5Benzinga Newsdesk - Sep 21, 2023, 8:22AM
Wednesday, September 20, 2023
- Vericel Announces U.S. Commercial Availability Of NexoBrid For The Treatment Of Severe Thermal Burns In AdultsHappy Mohamed - Sep 20, 2023, 4:31PM
- Vericel's Short Report: Deep Dive Into Knee-Repair Focused Company's 27 Years of LossesVandana Singh - Sep 20, 2023, 12:04PM
- Watching Vericel Corp.; J Capital Research Issues Short Report On CoBenzinga Newsdesk - Sep 20, 2023, 10:36AM
Tuesday, August 29, 2023
Tuesday, August 08, 2023
Thursday, August 03, 2023
Wednesday, August 02, 2023
- Earnings Scheduled For August 2, 2023Benzinga Insights - Aug 2, 2023, 8:45AM
- MediWound Said Partner Vericel Has Received The First Lot Of Nexobrid Finished Product From Mediwound For The U.S. Commercial Market In June 2023Charles Gross - Aug 2, 2023, 8:04AM
- Vericel Revises FY23 Revenue Guidence To $190M-$197M From $184M-$192M Vs $190.29M Est.Happy Mohamed - Aug 2, 2023, 7:57AM
- Vericel Q2 EPS $(0.11) Beats $(0.13) Estimate, Sales $45.92M Beat $42.81M EstimateHappy Mohamed - Aug 2, 2023, 7:56AM
Wednesday, July 19, 2023
Thursday, May 11, 2023
Wednesday, May 10, 2023
- Earnings Scheduled For May 10, 2023Benzinga Insights - May 10, 2023, 9:12AM
- Vericel: Q1 Earnings InsightsBenzinga Insights - May 10, 2023, 8:16AM
- Vericel Raises FY23 Revenue Guidance To $184M-$192M vs $186.54M Est.Benzinga Newsdesk - May 10, 2023, 7:57AM
- Vericel Q1 EPS $(0.16) Misses $(0.15) Estimate, Sales $41.00M Beat $37.87M EstimateBenzinga Newsdesk - May 10, 2023, 7:56AM